{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"bioRxiv"}],"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T03:57:31Z","timestamp":1790654251029,"version":"4.1.0"},"posted":{"date-parts":[[2026,9,3]]},"group-title":"Evolutionary Biology","reference-count":182,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.biorxiv.org\/about\/FAQ#license"}],"funder":[{"name":"National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services","award":["75N93021C00018"],"award-info":[{"award-number":["75N93021C00018"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,9,22]]},"abstract":"<jats:p>Anticipating antigenic evolution is essential for selecting effective seasonal influenza A\/H3N2 vaccine strains. To this end, we integrated data from multiple immunological assays spanning two decades into a unified Bayesian antigenic map. The map resolves twelve antigenic clusters advancing in discrete steps, with several clusters co-circulating in most seasons. In 15 of 21 seasons, the vaccine composition belonged to an earlier cluster than the dominant circulating cluster. We identified geometric features of antigenic space that accounted for three-quarters of the variation in vaccine effectiveness. The direction of each vaccine update relative to recent viral drift predicted effectiveness one season ahead out of sample. In every season, our analyses identified a virus that would have raised predicted effectiveness by 10 percentage points.<\/jats:p>","DOI":"10.64898\/2026.08.27.747648","type":"posted-content","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T19:10:15Z","timestamp":1788462615000},"source":"Crossref","is-referenced-by-count":0,"title":["Directional antigenic drift forecasts influenza vaccine effectiveness and guides strain selection"],"prefix":"10.64898","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-2681-6598","authenticated-orcid":false,"given":"Omid","family":"Arhami","sequence":"first","affiliation":[{"name":"Institute of Bioinformatics, University of Georgia, Athens, GA, USA"},{"name":"Center for Influenza Disease & Emergence Research (CIDER), University of Georgia, Athens, GA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7221-3801","authenticated-orcid":false,"given":"Pejman","family":"Rohani","sequence":"additional","affiliation":[{"name":"Institute of Bioinformatics, University of Georgia, Athens, GA, USA"},{"name":"Center for Influenza Disease & Emergence Research (CIDER), University of Georgia, Athens, GA, USA"},{"name":"Odum School of Ecology, University of Georgia, Athens, GA, USA"},{"name":"Department of Infectious Diseases, College of Veterinary Medicine, University of Georgia, Athens, GA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"54368","reference":[{"key":"2026092820250603000_2026.08.27.747648v2.1","doi-asserted-by":"publisher","DOI":"10.1111\/irv.12258"},{"key":"2026092820250603000_2026.08.27.747648v2.2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(16)00129-8"},{"key":"2026092820250603000_2026.08.27.747648v2.3","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciac653"},{"key":"2026092820250603000_2026.08.27.747648v2.4","doi-asserted-by":"publisher","DOI":"10.1126\/science.1097211"},{"key":"2026092820250603000_2026.08.27.747648v2.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2006.01.010"},{"key":"2026092820250603000_2026.08.27.747648v2.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2014.02.014"},{"key":"2026092820250603000_2026.08.27.747648v2.7","doi-asserted-by":"publisher","DOI":"10.1038\/nature13087"},{"key":"2026092820250603000_2026.08.27.747648v2.8","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7007-10-38"},{"key":"2026092820250603000_2026.08.27.747648v2.9","doi-asserted-by":"publisher","DOI":"10.7554\/elife.60067"},{"issue":"1","key":"2026092820250603000_2026.08.27.747648v2.10","doi-asserted-by":"crossref","first-page":"2336357","DOI":"10.1080\/21645515.2024.2336357","article-title":"Seasonal influenza vaccine performance and the potential benefits of mRNA vaccines","volume":"20","year":"2024","journal-title":"Human vaccines & immunotherapeutics"},{"key":"2026092820250603000_2026.08.27.747648v2.11","doi-asserted-by":"publisher","DOI":"10.1126\/science.1132745"},{"key":"2026092820250603000_2026.08.27.747648v2.12","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.01914"},{"key":"2026092820250603000_2026.08.27.747648v2.13","doi-asserted-by":"publisher","DOI":"10.1126\/science.1244730"},{"key":"2026092820250603000_2026.08.27.747648v2.14","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.24.14001"},{"key":"2026092820250603000_2026.08.27.747648v2.15","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jix074"},{"key":"2026092820250603000_2026.08.27.747648v2.16","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1218841110"},{"key":"2026092820250603000_2026.08.27.747648v2.17","first-page":"1900585","article-title":"Paradoxical cladeand age-specific vaccine effectiveness during the 2018\/19 influenza A(H3N2) epidemic in Canada: potential imprint-regulated effect of vaccine (I-REV)","volume":"24","year":"2019","journal-title":"Euro Surveill"},{"key":"2026092820250603000_2026.08.27.747648v2.18","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29402-5"},{"key":"2026092820250603000_2026.08.27.747648v2.19","doi-asserted-by":"publisher","DOI":"10.1126\/science.adq3003"},{"key":"2026092820250603000_2026.08.27.747648v2.20","doi-asserted-by":"publisher","DOI":"10.1126\/science.adw4964"},{"key":"2026092820250603000_2026.08.27.747648v2.21","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2517518122"},{"key":"2026092820250603000_2026.08.27.747648v2.22","doi-asserted-by":"publisher","DOI":"10.1186\/s40249-024-01218-z"},{"key":"2026092820250603000_2026.08.27.747648v2.23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-55840-y"},{"key":"2026092820250603000_2026.08.27.747648v2.24","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.03376-25"},{"key":"2026092820250603000_2026.08.27.747648v2.25","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2026.31.5.2600068"},{"key":"2026092820250603000_2026.08.27.747648v2.26","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiz543"},{"key":"2026092820250603000_2026.08.27.747648v2.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2021.01.032"},{"key":"2026092820250603000_2026.08.27.747648v2.28","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2103398118"},{"key":"2026092820250603000_2026.08.27.747648v2.29","doi-asserted-by":"publisher","DOI":"10.1126\/science.1256427"},{"key":"2026092820250603000_2026.08.27.747648v2.30","first-page":"2000103","article-title":"Interim estimates of 2019\/20 vaccine effectiveness during earlyseason co-circulation of influenza A and B viruses, Canada, February 2020","volume":"25","year":"2020","journal-title":"Euro Surveill."},{"key":"2026092820250603000_2026.08.27.747648v2.31","doi-asserted-by":"crossref","first-page":"6700","DOI":"10.1016\/j.vaccine.2012.08.045","article-title":"Distinguishing vaccine efficacy and effectiveness","volume":"30","year":"2012","journal-title":"Vaccine"},{"key":"2026092820250603000_2026.08.27.747648v2.32","doi-asserted-by":"publisher","DOI":"10.1098\/rsif.2007.0229"},{"key":"2026092820250603000_2026.08.27.747648v2.33","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kww064"},{"key":"2026092820250603000_2026.08.27.747648v2.34","unstructured":"K. P. Burnham , D. R. Anderson , Model Selection and Multimodel Inference: A Practical Information-Theoretic Approach (Springer, New York), 2 ed. (2002)."},{"key":"2026092820250603000_2026.08.27.747648v2.35","doi-asserted-by":"publisher","DOI":"10.2307\/2533961"},{"key":"2026092820250603000_2026.08.27.747648v2.36","doi-asserted-by":"publisher","DOI":"10.1890\/14-1639.1"},{"key":"2026092820250603000_2026.08.27.747648v2.37","doi-asserted-by":"publisher","DOI":"10.1080\/01621459.2013.823775"},{"key":"2026092820250603000_2026.08.27.747648v2.38","doi-asserted-by":"publisher","DOI":"10.2307\/1267351"},{"key":"2026092820250603000_2026.08.27.747648v2.39","doi-asserted-by":"publisher","DOI":"10.1198\/016214508000000337"},{"key":"2026092820250603000_2026.08.27.747648v2.40","doi-asserted-by":"crossref","unstructured":"O. Arhami , P. Rohani , Topolow: a mapping algorithm for antigenic cross-reactivity and binding affinity assays. Bioinformatics 41, btaf372 (2025).","DOI":"10.1093\/bioinformatics\/btaf372"},{"key":"2026092820250603000_2026.08.27.747648v2.41","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1093\/cid\/ciy323","article-title":"Predicting influenza H3N2 vaccine efficacy from evolution of the dominant epitope","volume":"67","year":"2018","journal-title":"Clin. Infect. Dis"},{"key":"2026092820250603000_2026.08.27.747648v2.42","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwy163"},{"key":"2026092820250603000_2026.08.27.747648v2.43","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2588"},{"key":"2026092820250603000_2026.08.27.747648v2.44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002802"},{"key":"2026092820250603000_2026.08.27.747648v2.45","doi-asserted-by":"publisher","DOI":"10.1016\/j.coviro.2016.12.004"},{"key":"2026092820250603000_2026.08.27.747648v2.46","doi-asserted-by":"publisher","DOI":"10.1016\/s2213-2600(22)00266-1"},{"key":"2026092820250603000_2026.08.27.747648v2.47","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp2202669"},{"key":"2026092820250603000_2026.08.27.747648v2.48","doi-asserted-by":"crossref","first-page":"707","DOI":"10.3390\/vaccines2040707","article-title":"Overview of serological techniques for influenza vaccine evaluation: past, present and future","volume":"2","year":"2014","journal-title":"Vaccines"},{"key":"2026092820250603000_2026.08.27.747648v2.49","doi-asserted-by":"crossref","unstructured":"K. A. Bollen , Structural Equations with Latent Variables (Wiley) (1989).","DOI":"10.1002\/9781118619179"},{"key":"2026092820250603000_2026.08.27.747648v2.50","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1016\/j.vaccine.2013.02.053","article-title":"The test-negative design for estimating influenza vaccine effectiveness","volume":"31","year":"2013","journal-title":"Vaccine"},{"key":"2026092820250603000_2026.08.27.747648v2.51","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit736"},{"key":"2026092820250603000_2026.08.27.747648v2.52","doi-asserted-by":"publisher","DOI":"10.1016\/j.tim.2017.09.004"},{"key":"2026092820250603000_2026.08.27.747648v2.53","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1712377114"},{"key":"2026092820250603000_2026.08.27.747648v2.54","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006682"},{"key":"2026092820250603000_2026.08.27.747648v2.55","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2019.04.013"},{"key":"2026092820250603000_2026.08.27.747648v2.56","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1400476111"},{"key":"2026092820250603000_2026.08.27.747648v2.57","unstructured":"Stan Development Team, Stan Modeling Language Users Guide and Reference Manual, Version 2.36 (2024), https:\/\/mc-stan.org."},{"key":"2026092820250603000_2026.08.27.747648v2.58","doi-asserted-by":"crossref","unstructured":"A. Gelman , et al., Bayesian Data Analysis (CRC Press), 3rd ed. (2013).","DOI":"10.1201\/b16018"},{"key":"2026092820250603000_2026.08.27.747648v2.59","doi-asserted-by":"publisher","DOI":"10.2307\/2289144"},{"key":"2026092820250603000_2026.08.27.747648v2.60","doi-asserted-by":"publisher","DOI":"10.18637\/jss.v076.i01"},{"key":"2026092820250603000_2026.08.27.747648v2.61","doi-asserted-by":"publisher","DOI":"10.5281\/zenodo.22902309"},{"key":"2026092820250603000_2026.08.27.747648v2.62","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.1016\/j.vaccine.2013.04.026","article-title":"The case test-negative design for studies of the effectiveness of influenza vaccine","volume":"31","year":"2013","journal-title":"Vaccine"},{"key":"2026092820250603000_2026.08.27.747648v2.63","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1010885"},{"key":"2026092820250603000_2026.08.27.747648v2.64","doi-asserted-by":"publisher","DOI":"10.1007\/s11222016-9696-4"},{"key":"2026092820250603000_2026.08.27.747648v2.65","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.psych.53.100901.135239"},{"key":"2026092820250603000_2026.08.27.747648v2.66","doi-asserted-by":"crossref","unstructured":"S. A. Frank , Immunology and Evolution of Infectious Disease (Princeton Univ. Press) (2002).","DOI":"10.1515\/9780691220161"},{"key":"2026092820250603000_2026.08.27.747648v2.67","doi-asserted-by":"publisher","DOI":"10.1017\/S0266466605050036"},{"issue":"1","key":"2026092820250603000_2026.08.27.747648v2.68","first-page":"31","article-title":"Let\u2019s Take the Con Out of Econometrics","volume":"73","year":"1983","journal-title":"The American Economic Review"},{"key":"2026092820250603000_2026.08.27.747648v2.69","doi-asserted-by":"publisher","DOI":"10.2307\/1924497"},{"issue":"2","key":"2026092820250603000_2026.08.27.747648v2.70","first-page":"178","article-title":"I Just Ran Two Million Regressions","volume":"87","year":"1997","journal-title":"The American Economic Review"},{"key":"2026092820250603000_2026.08.27.747648v2.71","doi-asserted-by":"publisher","DOI":"10.1002\/ecm.1309"},{"key":"2026092820250603000_2026.08.27.747648v2.72","doi-asserted-by":"publisher","DOI":"10.1002\/eap.1419"},{"key":"2026092820250603000_2026.08.27.747648v2.73","doi-asserted-by":"publisher","DOI":"10.1038\/s41562-020-0912-z"},{"key":"2026092820250603000_2026.08.27.747648v2.74","unstructured":"R. H. Lindeman , P. F. Merenda , R. Z. Gold , Introduction to Bivariate and Multivariate Analysis (Scott, Foresman, Glenview, IL) (1980)."},{"key":"2026092820250603000_2026.08.27.747648v2.75","doi-asserted-by":"publisher","DOI":"10.1198\/000313007X188252"},{"key":"2026092820250603000_2026.08.27.747648v2.76","doi-asserted-by":"publisher","DOI":"10.1016\/0197-2456(86)90046-2"},{"key":"2026092820250603000_2026.08.27.747648v2.77","doi-asserted-by":"publisher","DOI":"10.1111\/j.1467-985X.2008.00552.x"},{"key":"2026092820250603000_2026.08.27.747648v2.78","doi-asserted-by":"crossref","unstructured":"R. J. Carroll , D. Ruppert , L. A. Stefanski , C. M. Crainiceanu , Measurement Error in Nonlinear Models: A Modern Perspective (Chapman and Hall\/CRC, Boca Raton, FL), 2 ed. (2006).","DOI":"10.1201\/9781420010138"},{"key":"2026092820250603000_2026.08.27.747648v2.79","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmp.2018.12.004"},{"key":"2026092820250603000_2026.08.27.747648v2.80","doi-asserted-by":"publisher","DOI":"10.1214\/06-BA117A"},{"key":"2026092820250603000_2026.08.27.747648v2.81","doi-asserted-by":"publisher","DOI":"10.1214\/08-AOAS191"},{"key":"2026092820250603000_2026.08.27.747648v2.82","first-page":"1593","article-title":"The No-U-Turn Sampler: Adaptively Setting Path Lengths in Hamiltonian Monte Carlo","volume":"15","year":"2014","journal-title":"Journal of Machine Learning Research"},{"key":"2026092820250603000_2026.08.27.747648v2.83","doi-asserted-by":"crossref","unstructured":"M. Betancourt , A Conceptual Introduction to Hamiltonian Monte Carlo (2017), arXiv:1701.02434.","DOI":"10.3150\/16-BEJ810"},{"key":"2026092820250603000_2026.08.27.747648v2.84","doi-asserted-by":"publisher","DOI":"10.1080\/00031305.2018.1549100"},{"key":"2026092820250603000_2026.08.27.747648v2.85","doi-asserted-by":"crossref","unstructured":"J. O. Berger , Statistical Decision Theory and Bayesian Analysis (Springer, New York), 2 ed. (1985).","DOI":"10.1007\/978-1-4757-4286-2"},{"key":"2026092820250603000_2026.08.27.747648v2.86","unstructured":"C. P. Robert , The Bayesian Choice: From Decision-Theoretic Foundations to Computational Implementation (Springer, New York), 2 ed. (2007)."},{"key":"2026092820250603000_2026.08.27.747648v2.87","doi-asserted-by":"publisher","DOI":"10.1023\/A:1008306431147"},{"key":"2026092820250603000_2026.08.27.747648v2.88","doi-asserted-by":"publisher","DOI":"10.1198\/jasa.2011.tm11181"},{"key":"2026092820250603000_2026.08.27.747648v2.89","doi-asserted-by":"publisher","DOI":"10.1214\/12-AOS1077"},{"key":"2026092820250603000_2026.08.27.747648v2.90","doi-asserted-by":"publisher","DOI":"10.1084\/jem.75.1.49"},{"key":"2026092820250603000_2026.08.27.747648v2.91","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-019-0143-6"},{"key":"2026092820250603000_2026.08.27.747648v2.92","doi-asserted-by":"crossref","first-page":"1155552","DOI":"10.3389\/fimmu.2023.1155552","article-title":"Haemagglutination inhibition and virus microneutralisation serology assays: use of harmonised protocols and biological standards in seasonal influenza serology testing and their impact on inter-laboratory variation and assay correlation: a FLUCOP collaborative study","volume":"14","year":"2023","journal-title":"Front. Immunol"},{"key":"2026092820250603000_2026.08.27.747648v2.93","doi-asserted-by":"publisher","DOI":"10.1586\/eri.11.51"},{"key":"2026092820250603000_2026.08.27.747648v2.94","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.11.019"},{"key":"2026092820250603000_2026.08.27.747648v2.95","doi-asserted-by":"publisher","DOI":"10.3201\/eid1508.081754"},{"key":"2026092820250603000_2026.08.27.747648v2.96","doi-asserted-by":"publisher","DOI":"10.1111\/irv.12408"},{"key":"2026092820250603000_2026.08.27.747648v2.97","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1128\/JCM.00229-11","article-title":"Sensitivity and specificity of serologic assays for detection of human infection with 2009 pandemic H1N1 virus in U","volume":"49","year":"2011","journal-title":"S. populations. J. Clin. Microbiol"},{"key":"2026092820250603000_2026.08.27.747648v2.98","doi-asserted-by":"publisher","DOI":"10.1111\/j.1750-2659.2007.00016.x"},{"key":"2026092820250603000_2026.08.27.747648v2.99","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.07.079"},{"key":"2026092820250603000_2026.08.27.747648v2.100","doi-asserted-by":"publisher","DOI":"10.1017\/S0022172400022610"},{"key":"2026092820250603000_2026.08.27.747648v2.101","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-018-0157-4"},{"key":"2026092820250603000_2026.08.27.747648v2.102","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3390\/v17010104","article-title":"Comparative analysis of hemagglutination inhibition and plaque reduction neutralization tests for Japanese encephalitis virus antibody detection","volume":"17","year":"2025","journal-title":"Viruses"},{"key":"2026092820250603000_2026.08.27.747648v2.103","doi-asserted-by":"crossref","unstructured":"Y. Park , et al., Comparison of plaque reduction and focus reduction neutralization tests for the measurement of neutralizing antibody titers against Japanese encephalitis virus. J. Virol. Methods 306, 114540 (2022).","DOI":"10.1016\/j.jviromet.2022.114540"},{"key":"2026092820250603000_2026.08.27.747648v2.104","doi-asserted-by":"publisher","DOI":"10.1016\/j.jviromet.2005.12.010"},{"key":"2026092820250603000_2026.08.27.747648v2.105","first-page":"2000421","article-title":"Serological assays for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), March 2020","volume":"25","year":"2020","journal-title":"Euro Surveill."},{"key":"2026092820250603000_2026.08.27.747648v2.106","doi-asserted-by":"publisher","DOI":"10.1080\/21505594.2023.2235459"},{"key":"2026092820250603000_2026.08.27.747648v2.107","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00458-10"},{"key":"2026092820250603000_2026.08.27.747648v2.108","doi-asserted-by":"publisher","DOI":"10.1099\/jgv.0.000809"},{"key":"2026092820250603000_2026.08.27.747648v2.109","doi-asserted-by":"crossref","unstructured":"L. Kaufman , P. J. Rousseeuw , Finding Groups in Data: An Introduction to Cluster Analysis (Wiley, New York) (1990).","DOI":"10.1002\/9780470316801"},{"key":"2026092820250603000_2026.08.27.747648v2.110","doi-asserted-by":"crossref","unstructured":"Y. Liu , Z. Li , H. Xiong , X. Gao , J. Wu , Understanding of internal clustering validation measures, in Proc. 10th IEEE Int. Conf. Data Mining (2010), pp. 911\u2013916.","DOI":"10.1109\/ICDM.2010.35"},{"key":"2026092820250603000_2026.08.27.747648v2.111","doi-asserted-by":"publisher","DOI":"10.1093\/comjnl\/20.4.359"},{"key":"2026092820250603000_2026.08.27.747648v2.112","doi-asserted-by":"publisher","DOI":"10.1016\/0377-0427(87)90125-7"},{"key":"2026092820250603000_2026.08.27.747648v2.113","doi-asserted-by":"publisher","DOI":"10.1109\/tpami.2005.113"},{"key":"2026092820250603000_2026.08.27.747648v2.114","doi-asserted-by":"publisher","DOI":"10.1214\/10-STS330"},{"key":"2026092820250603000_2026.08.27.747648v2.115","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-72716-1"},{"key":"2026092820250603000_2026.08.27.747648v2.116","doi-asserted-by":"publisher","DOI":"10.1214\/20-BA1221"},{"key":"2026092820250603000_2026.08.27.747648v2.117","doi-asserted-by":"publisher","DOI":"10.1198\/016214506000001437"},{"key":"2026092820250603000_2026.08.27.747648v2.118","doi-asserted-by":"publisher","DOI":"10.1111\/j.1467-9868.2007.00587.x"},{"key":"2026092820250603000_2026.08.27.747648v2.119","doi-asserted-by":"publisher","DOI":"10.2307\/2981683"},{"key":"2026092820250603000_2026.08.27.747648v2.120","doi-asserted-by":"publisher","DOI":"10.1086\/595861"},{"key":"2026092820250603000_2026.08.27.747648v2.121","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1700153"},{"key":"2026092820250603000_2026.08.27.747648v2.122","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy775"},{"key":"2026092820250603000_2026.08.27.747648v2.123","doi-asserted-by":"publisher","DOI":"10.1086\/595862"},{"key":"2026092820250603000_2026.08.27.747648v2.124","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw176"},{"key":"2026092820250603000_2026.08.27.747648v2.125","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiaa138"},{"key":"2026092820250603000_2026.08.27.747648v2.126","doi-asserted-by":"publisher","DOI":"10.2807\/ese.18.05.20390-en"},{"key":"2026092820250603000_2026.08.27.747648v2.127","doi-asserted-by":"crossref","first-page":"100042","DOI":"10.1016\/j.jvacx.2019.100042","article-title":"Effectiveness of influenza vaccine against influenza A in Europe in seasons of different A(H1N1)pdm09 and the same A(H3N2) vaccine components (2016\u201317 and 2017\u201318)","volume":"3","year":"2019","journal-title":"Vaccine X"},{"key":"2026092820250603000_2026.08.27.747648v2.128","doi-asserted-by":"crossref","first-page":"e13243","DOI":"10.1111\/irv.13243","article-title":"Influenza vaccine effectiveness in Europe: results from the 2022\u20132023 VEBIS (Vaccine Effectiveness, Burden and Impact Studies) primary care multicentre study","volume":"18","year":"2024","journal-title":". Influenza Other Respir. Viruses"},{"key":"2026092820250603000_2026.08.27.747648v2.129","first-page":"30464","article-title":"I-MOVE\/I-MOVE+ study team, Early 2016\/17 vaccine effectiveness estimates against influenza A(H3N2): I-MOVE multicentre case control studies at primary care and hospital levels in Europe","volume":"22","year":"2017","journal-title":"Euro Surveill"},{"key":"2026092820250603000_2026.08.27.747648v2.130","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiv177"},{"key":"2026092820250603000_2026.08.27.747648v2.131","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1884"},{"key":"2026092820250603000_2026.08.27.747648v2.132","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1109314108"},{"key":"2026092820250603000_2026.08.27.747648v2.133","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.07.002"},{"key":"2026092820250603000_2026.08.27.747648v2.134","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis574"},{"key":"2026092820250603000_2026.08.27.747648v2.135","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiu647"},{"key":"2026092820250603000_2026.08.27.747648v2.136","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiv577"},{"key":"2026092820250603000_2026.08.27.747648v2.137","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw635"},{"key":"2026092820250603000_2026.08.27.747648v2.138","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1093\/cid\/ciz075","article-title":"Effects of influenza vaccination in the United States during the 2017\u20132018 influenza season","volume":"69","year":"2019","journal-title":"Clin. Infect. Dis"},{"key":"2026092820250603000_2026.08.27.747648v2.139","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciac941"},{"key":"2026092820250603000_2026.08.27.747648v2.140","doi-asserted-by":"crossref","first-page":"e184","DOI":"10.1093\/cid\/ciae658","article-title":"Influenza vaccine effectiveness against medically attended outpatients illness, United States, 2023\u20132024 season","volume":"81","year":"2025","journal-title":"Clin. Infect. Dis."},{"key":"2026092820250603000_2026.08.27.747648v2.141","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7406a2"},{"key":"2026092820250603000_2026.08.27.747648v2.142","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7509a2"},{"key":"2026092820250603000_2026.08.27.747648v2.143","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jis283"},{"key":"2026092820250603000_2026.08.27.747648v2.144","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis431"},{"key":"2026092820250603000_2026.08.27.747648v2.145","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0092153"},{"key":"2026092820250603000_2026.08.27.747648v2.146","first-page":"2200720","article-title":"Influenza vaccine effectiveness against A(H3N2) during the delayed 2021\/22 epidemic in Canada","volume":"27","year":"2022","journal-title":"Euro Surveill"},{"key":"2026092820250603000_2026.08.27.747648v2.147","first-page":"2300043","article-title":"Vaccine effectiveness estimates from an early-season influenza A(H3N2) epidemic, including unique genetic diversity with reassortment, Canada, 2022\/23","volume":"28","year":"2023","journal-title":"Euro Surveill."},{"key":"2026092820250603000_2026.08.27.747648v2.148","first-page":"2400076","article-title":"2023\/24 mid-season influenza and Omicron XBB.1.5 vaccine effectiveness estimates from the Canadian Sentinel Practitioner Surveillance Network (SPSN)","volume":"29","year":"2024","journal-title":"Euro Surveill."},{"key":"2026092820250603000_2026.08.27.747648v2.149","first-page":"2500059","article-title":"Interim estimates of vaccine effectiveness against influenza A(H1N1)pdm09 and A(H3N2) during a delayed influenza season, Canada, 2024\/25","volume":"30","year":"2025","journal-title":"Euro Surveill."},{"key":"2026092820250603000_2026.08.27.747648v2.150","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES2014.19.6.20701"},{"key":"2026092820250603000_2026.08.27.747648v2.151","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1016\/j.vaccine.2015.04.012","article-title":"The European I-MOVE multicentre 2013\u20132014 case\u2013control study. Homogeneous moderate influenza vaccine effectiveness against A(H1N1)pdm09 and heterogenous results by country against A(H3N2)","volume":"33","year":"2015","journal-title":"Vaccine"},{"key":"2026092820250603000_2026.08.27.747648v2.152","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2016.21.7.30139"},{"key":"2026092820250603000_2026.08.27.747648v2.153","first-page":"1900604","article-title":"Low 2018\/19 vaccine effectiveness against influenza A(H3N2) among 15\u201364-year-olds in Europe: exploration by birth cohort","volume":"24","year":"2019","journal-title":"Euro Surveill"},{"key":"2026092820250603000_2026.08.27.747648v2.154","first-page":"2000153","article-title":"Interim 2019\/20 influenza vaccine effectiveness: six European studies, September 2019 to January 2020","volume":"25","year":"2020","journal-title":"Euro Surveill."},{"key":"2026092820250603000_2026.08.27.747648v2.155","doi-asserted-by":"crossref","first-page":"e13069","DOI":"10.1111\/irv.13069","article-title":"Influenza vaccine effectiveness against influenza A subtypes in Europe: results from the 2021\u20132022 I-MOVE primary care multicentre study","volume":"17","year":"2023","journal-title":"Influenza Other Respir. Viruses"},{"key":"2026092820250603000_2026.08.27.747648v2.156","first-page":"2500011","article-title":"Influenza vaccine effectiveness in Europe and the birth cohort effect against influenza A(H1N1)pdm09: VEBIS primary care multicentre study, 2023\/24","volume":"30","year":"2025","journal-title":"Euro Surveill."},{"key":"2026092820250603000_2026.08.27.747648v2.157","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2025.30.7.2500102"},{"key":"2026092820250603000_2026.08.27.747648v2.158","first-page":"2600109","article-title":"Influenza vaccine effectiveness from nine studies during drifted A(H3N2) subclade K predominance, Europe, September 2025 to January 2026","volume":"31","year":"2026","journal-title":"Euro Surveill."},{"key":"2026092820250603000_2026.08.27.747648v2.159","first-page":"30460","article-title":"Interim estimates of 2016\/17 vaccine effectiveness against influenza A(H3N2), Canada, January 2017","volume":"22","year":"2017","journal-title":"Euro Surveill."},{"key":"2026092820250603000_2026.08.27.747648v2.160","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz411"},{"key":"2026092820250603000_2026.08.27.747648v2.161","doi-asserted-by":"publisher","DOI":"10.5694\/mja14.00106"},{"key":"2026092820250603000_2026.08.27.747648v2.162","unstructured":"Centers for Disease Control and Prevention, FluVaxView: Influenza vaccination coverage by season (2025), https:\/\/www.cdc.gov\/fluvaxview\/coverage-by-season\/index.html.Interactivereportanddataexport; accessed 14 August 2026."},{"key":"2026092820250603000_2026.08.27.747648v2.163","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwt158"},{"key":"2026092820250603000_2026.08.27.747648v2.164","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.97"},{"issue":"1","key":"2026092820250603000_2026.08.27.747648v2.165","first-page":"38","article-title":"Influenza vaccination coverage \u2014 United States, 2000\u20132010","volume":"60","year":"2011","journal-title":"MMWR Suppl."},{"issue":"37","key":"2026092820250603000_2026.08.27.747648v2.166","first-page":"953","article-title":"State-specific influenza vaccination coverage among adults aged \u226518 years \u2014 United States, 2003\u201304 and 2005\u201306 influenza seasons","volume":"56","author":"Centers for Disease Control and Prevention","year":"2007","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"issue":"38","key":"2026092820250603000_2026.08.27.747648v2.167","first-page":"1033","article-title":"State-specific influenza vaccination coverage among adults \u2014 United States, 2006\u201307 influenza season","volume":"57","author":"Centers for Disease Control and Prevention","year":"2008","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"issue":"39","key":"2026092820250603000_2026.08.27.747648v2.168","first-page":"1091","article-title":"Influenza vaccination coverage among children and adults \u2014 United States, 2008\u201309 influenza season","volume":"58","author":"Centers for Disease Control and Prevention","year":"2009","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"2026092820250603000_2026.08.27.747648v2.169","unstructured":"Eurostat, Influenza vaccination rate, people aged 65 years or over, EU, 2009\u20132023 (online data code: hlth ps immu) (2024), https:\/\/ec.europa.eu\/eurostat\/databrowser\/view\/hlth_ps_immu. Accessed 14 August 2026."},{"key":"2026092820250603000_2026.08.27.747648v2.170","unstructured":"European Centre for Disease Prevention and Control, Seasonal influenza vaccination in Eu-rope: vaccination recommendations and coverage rates in the EU Member States for eight influenza seasons, 2007\u20132008 to 2014\u20132015, Tech. rep., ECDC, Stockholm (2017), iSBN 978-92-9498-076-2."},{"key":"2026092820250603000_2026.08.27.747648v2.171","unstructured":"European Centre for Disease Prevention and Control, Seasonal influenza vaccination and antiviral use in EU\/EEA Member States: overview of vaccine recommendations for 2017\u2013 2018 and vaccination coverage rates for 2015\u20132016 and 2016\u20132017 influenza seasons, Tech. rep., ECDC, Stockholm (2018)."},{"issue":"4","key":"2026092820250603000_2026.08.27.747648v2.172","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.vaccine.2017.12.019","article-title":"How close are countries of the WHO European Region to achieving the goal of vaccinating 75% of key risk groups against influenza? Results from national surveys on seasonal influenza vaccination programmes, 2008\/2009 to 2014\/2015","volume":"36","year":"2018","journal-title":"Vaccine"},{"issue":"11","key":"2026092820250603000_2026.08.27.747648v2.173","first-page":"2706","article-title":"Impact of European vaccination policies on seasonal influenza vaccination coverage rates: an update seven years later","volume":"14","year":"2018","journal-title":"Hum. Vaccin. Immunother"},{"key":"2026092820250603000_2026.08.27.747648v2.174","unstructured":"European Centre for Disease Prevention and Control, Survey report on national seasonal influenza vaccination recommendations and coverage rates in EU\/EEA countries (2024 survey; data for 2021\u201322 to 2023\u201324 seasons), Tech. rep., ECDC, Stockholm (2024)."},{"key":"2026092820250603000_2026.08.27.747648v2.175","unstructured":"European Centre for Disease Prevention and Control, Survey report on national seasonal influenza vaccination recommendations and coverage rates in EU\/EEA countries, 2024\/25, Tech. rep., ECDC, Stockholm (2025), iSBN 978-92-9498-840-9."},{"issue":"5\u20136","key":"2026092820250603000_2026.08.27.747648v2.176","first-page":"215","article-title":"Influenza vaccination coverage rates in Europe \u2014 covering five consecutive seasons (2001\u20132006) in five countries","volume":"1","year":"2008","journal-title":"Influenza Other Respir. Viruses"},{"key":"2026092820250603000_2026.08.27.747648v2.177","doi-asserted-by":"publisher","DOI":"10.9778\/cmajo.20160050"},{"key":"2026092820250603000_2026.08.27.747648v2.178","unstructured":"L. Gionet , Flu vaccination rates in Canada (2015), health at a Glance, Statistics Canada Cat. no. 82-624-X."},{"key":"2026092820250603000_2026.08.27.747648v2.179","doi-asserted-by":"publisher","DOI":"10.25318\/1310009601-eng"},{"issue":"2","key":"2026092820250603000_2026.08.27.747648v2.180","first-page":"33","article-title":"Influenza vaccination","volume":"15","year":"2004","journal-title":"Health Rep."},{"key":"2026092820250603000_2026.08.27.747648v2.181","unstructured":"Public Health Agency of Canada, Highlights from the 2022\u20132023 Seasonal Influenza (Flu) Vaccination Coverage Survey (2023), https:\/\/www.canada.ca\/en\/public-health\/services\/immunization-vaccines\/vaccination-coverage\/seasonal-influenza-survey-results-2022-2023.html. Accessed 14 August 2026."},{"key":"2026092820250603000_2026.08.27.747648v2.182","doi-asserted-by":"publisher","DOI":"10.14745\/ccdr.v49i10a02"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.64898\/2026.08.27.747648","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T03:25:30Z","timestamp":1790652330000},"score":1,"resource":{"primary":{"URL":"http:\/\/biorxiv.org\/lookup\/doi\/10.64898\/2026.08.27.747648"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,3]]},"references-count":182,"URL":"https:\/\/doi.org\/10.64898\/2026.08.27.747648","relation":{},"subject":[],"published":{"date-parts":[[2026,9,3]]},"subtype":"preprint"}}